Aimei Health Technology (AFJK) & The Competition Head to Head Comparison

Aimei Health Technology (NASDAQ:AFJK) is one of 89 publicly-traded companies in the “UNCLASSIFIED” industry, but how does it weigh in compared to its competitors? We will compare Aimei Health Technology to related businesses based on the strength of its institutional ownership, valuation, earnings, risk, profitability, dividends and analyst recommendations.

Risk and Volatility

Aimei Health Technology has a beta of -0.02, suggesting that its share price is 102% less volatile than the S&P 500. Comparatively, Aimei Health Technology’s competitors have a beta of -0.08, suggesting that their average share price is 108% less volatile than the S&P 500.

Institutional & Insider Ownership

45.6% of Aimei Health Technology shares are owned by institutional investors. Comparatively, 51.0% of shares of all “UNCLASSIFIED” companies are owned by institutional investors. 2.5% of Aimei Health Technology shares are owned by company insiders. Comparatively, 42.7% of shares of all “UNCLASSIFIED” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Valuation and Earnings

This table compares Aimei Health Technology and its competitors gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Aimei Health Technology	N/A	$2.55 million	48.30
Aimei Health Technology Competitors	$47.83 million	-$19.62 million	93.63

Aimei Health Technology’s competitors have higher revenue, but lower earnings than Aimei Health Technology. Aimei Health Technology is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Aimei Health Technology and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Aimei Health Technology	N/A	-95.88%	3.06%
Aimei Health Technology Competitors	0.86%	0.95%	0.80%

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Aimei Health Technology and its competitors, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aimei Health Technology	1	0	0	0	1.00
Aimei Health Technology Competitors	206	262	217	3	2.02

As a group, “UNCLASSIFIED” companies have a potential upside of 79.61%. Given Aimei Health Technology’s competitors stronger consensus rating and higher possible upside, analysts clearly believe Aimei Health Technology has less favorable growth aspects than its competitors.

Summary

Aimei Health Technology competitors beat Aimei Health Technology on 10 of the 13 factors compared.

About Aimei Health Technology

Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.